SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-13-000935
Filing Date
2013-08-02
Accepted
2013-08-02 13:39:50
Documents
3
Group Members
DAVID A. HURWITZJOHN T. BIRDNEIL H. KOFFLERPETER M. COLLERYSC FUNDAMENTAL LLCSC FUNDAMENTAL LLC EMPLOYEE SAVINGS & PROFIT SHARING PLANSC FUNDAMENTAL VALUE FUND, L.P

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G fundamental_13g.htm SC 13G 130312
2 EXHIBIT1 ex_1.htm EX-1 10152
3 EXHIBIT 2 ex_2.htm EX-2 2559
  Complete submission text file 0001019056-13-000935.txt   144981
Mailing Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804
Business Address 1003 W. CUTTING BLVD SUITE 110 POINT RICHMOND CA 94804 (510) 215-3500
Transcept Pharmaceuticals Inc (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81821 | Film No.: 131005782
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SC FUNDAMENTAL LLC 747 THIRD AVENUE, 27TH FLOOR NEW YORK NY 10017
Business Address C/O SC FUNDAMENTAL LLC 747 THIRD AVENUE, 27TH FLOOR NEW YORK NY 10017 212-888-9100
SC Fundamental Value Fund, L.P. (Filed by) CIK: 0001322318 (see all company filings)

IRS No.: 133563962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G